Aerpio Pharmaceuticals Announces Nomination of Industry Veteran Cheryl Cohen to Board of Directors

CINCINNATI--(BUSINESS WIRE)--Aerpio Pharmaceuticals, Inc. (OTCQB:ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, today announced the nomination of a new director, Cheryl Cohen, to its Board of Directors. Ms. Cohen will stand for election at Aerpio’s 2018 Annual Meeting of Stockholders on June 20, 2018. If approved, Ms. Cohen will bring to Aerpio more than 25 years of experience in the biopharmaceutical industry, with a focus on strategic pr

Full Story →